Sanofi Reaches New 52-Week High (SNY)

NEW YORK ( TheStreet) -- Sanofi (NYSE: SNY) hit a new 52-week high Monday as it is currently trading at $41.77, above its previous 52-week high of $41.73 with 294,682 shares traded as of 10:05 a.m. ET. Average volume has been 3.6 million shares over the past 30 days.

Sanofi has a market cap of $105.8 billion and is part of the health care sector and drugs industry. Shares are up 10.7% year to date as of the close of trading on Friday.

Sanofi, together with its subsidiaries, researches, develops, manufactures, and markets healthcare products worldwide. The company has a P/E ratio of 21.5, above the average drugs industry P/E ratio of 14.4 and above the S&P 500 P/E ratio of 17.7.

TheStreet Ratings rates Sanofi as a buy. The company's strengths can be seen in multiple areas, such as its largely solid financial position with reasonable debt levels by most measures, attractive valuation levels, expanding profit margins, increase in stock price during the past year and notable return on equity. We feel these strengths outweigh the fact that the company has had sub par growth in net income. You can view the full Sanofi Ratings Report.

See all 52-week high stocks or get investment ideas from our investment research center.
null

If you liked this article you might like

Biotech Mailbag: Buy Dip in T2 Biosystems?

FDA Official Calls for Ending Codeine Use in Kids Cough Products

Big Drug Makers Could Face More Pressure on Codeine Remedies for Kids

Sanofi Has Good Potential Upside

European Pharma Companies Slip on MS Pricing Probe